# RASAGILINE MESYLATE
> **ANDA201971** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 2017-05-15
## Drug
- **FDA Application Number:** ANDA201971
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RASAGILINE MESYLATE
- **Generic name:** Rasagiline Mesylate
- **Active ingredients:** RASAGILINE MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA USA
- **First approval:** 2017-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201971)
---
*MORVS · CC0 1.0*